Antipsychotic metabolic monitoring — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Weight, metabolic parameters and cardiovascular risk monitoring
Olanzapine is associated with weight gain, dyslipidaemia and glucose dysregulation. Baseline and ongoing metabolic monitoring are important. The other monitoring tests are not routine for olanzapine.
Reference: BNF; NICE CKS